CIM
SNY icon

Contravisory Investment Management’s Sanofi SNY Stock Holding History

Contravisory Investment Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,300
Closed -$63K – 424
2025
Q4 		$63K Hold
1,300
– – 0.01% 268
2025
Q3 		$61.4K Sell
1,300
-1,375
-51% -$66.4K 0.01% 270
2025
Q2 		$129K Sell
2,675
-14,285
-84% -$730K 0.03% 265
2025
Q1 		$941K Buy
+16,960
New +$918K 0.2% 66
2018
Q1 		– Sell
-9
Closed – – 442
2017
Q4 		$0 Buy
+9
New +$415 ﹤0.01% 516

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Contravisory Investment Management's SNY Position: Q1 2026 in Review

Contravisory Investment Management sold out of Sanofi (SNY) in Q1 2026, closing a stake of 1,300 shares — an estimated $63K sold.

Contravisory Investment Management first reported a position in SNY in Q4 2017 and held it in 5 quarters. The position peaked at $941K in Q1 2025. 744 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Contravisory Investment Management reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Contravisory Investment Management sold 1,300 Sanofi shares in Q1 2026, an estimated $63K.
  • Contravisory Investment Management first reported a position in Sanofi in Q4 2017 and held it in 5 quarters.
  • Contravisory Investment Management's Sanofi position peaked at $941K in Q1 2025.
  • 744 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Contravisory Investment Management's 13F filing for Q1 2026, filed 20 Apr 2026.